Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinxin Zou

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
National Science Review|June 16, 2023
Data quantity governance for machine learning in materials scienceYue Liu, Zhengwei Yang, Xinxin Zou, et al.
Frontiers in Medicine|December 31, 2021
Mucinous Ovarian Tumors With Anaplastic Mural Nodules: Case ReportXinxin Zou, Hao Huang, Qingyu Zhang, et al.
Experimental and Therapeutic Medicine|January 3, 2022
Feibi decoction-medicated serum inhibits lipopolysaccharide-induced inflammation in RAW264.7 cells and BMDMsWan Wei, Guodong Li, Zhaoheng Liu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 16, 2018
Number 2 Feibi Recipe Reduces PM2.5-Induced Lung Injury in RatsZhaoheng Liu, Wei Wang, Fang Cao, et al.
Neuroscience Letters|March 26, 2023
Determination of the role of hippocampal astrocytes in the bilateral common carotid artery stenosis mouse model by RNA sequencingJiangnan Li, Xinxin Zou, Rui Mao, et al.
Life Sciences|December 26, 2024
Sinomenine modulates the metabolic reprogramming induced by sepsis via CHRNA7Jie Zhao, Zi Wang, Xinxin Zou, et al.
CNS Neuroscience & Therapeutics|July 5, 2025
Dehydrocostus Lactone Inhibits Microglia-Mediated Neuroinflammation by Targeting CYP2A6 to Improve Ischemic Brain InjuryXin Shu, Xinxin Zou, Jingxuan Zhang, et al.
International Immunopharmacology|April 20, 2025
Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseasesHuaiping Tang, Xinxin Zou, Peipei Chen, et al.
International Immunopharmacology|November 23, 2025
Corrigendum to "Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases" [Int. Immunopharmacol. 156 (2025) 114687]Huaiping Tang, Xinxin Zou, Peipei Chen, et al.
Biomedical Materials (Bristol, England)|June 5, 2024
Carboxymethyl chitosan-methacrylic acid gelatin hydrogel for wound healing and vascular regenerationJingrong Yu, Zhengkun Gao, Qingyue Han, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
National Science Review|June 16, 2023
Data quantity governance for machine learning in materials scienceYue Liu, Zhengwei Yang, Xinxin Zou, et al.
Frontiers in Medicine|December 31, 2021
Mucinous Ovarian Tumors With Anaplastic Mural Nodules: Case ReportXinxin Zou, Hao Huang, Qingyu Zhang, et al.
Experimental and Therapeutic Medicine|January 3, 2022
Feibi decoction-medicated serum inhibits lipopolysaccharide-induced inflammation in RAW264.7 cells and BMDMsWan Wei, Guodong Li, Zhaoheng Liu, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 16, 2018
Number 2 Feibi Recipe Reduces PM2.5-Induced Lung Injury in RatsZhaoheng Liu, Wei Wang, Fang Cao, et al.
Neuroscience Letters|March 26, 2023
Determination of the role of hippocampal astrocytes in the bilateral common carotid artery stenosis mouse model by RNA sequencingJiangnan Li, Xinxin Zou, Rui Mao, et al.
Life Sciences|December 26, 2024
Sinomenine modulates the metabolic reprogramming induced by sepsis via CHRNA7Jie Zhao, Zi Wang, Xinxin Zou, et al.
CNS Neuroscience & Therapeutics|July 5, 2025
Dehydrocostus Lactone Inhibits Microglia-Mediated Neuroinflammation by Targeting CYP2A6 to Improve Ischemic Brain InjuryXin Shu, Xinxin Zou, Jingxuan Zhang, et al.
International Immunopharmacology|April 20, 2025
Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseasesHuaiping Tang, Xinxin Zou, Peipei Chen, et al.
International Immunopharmacology|November 23, 2025
Corrigendum to "Broxyquinoline targets NLRP3 to inhibit inflammasome activation and alleviate NLRP3-associated inflammatory diseases" [Int. Immunopharmacol. 156 (2025) 114687]Huaiping Tang, Xinxin Zou, Peipei Chen, et al.
Biomedical Materials (Bristol, England)|June 5, 2024
Carboxymethyl chitosan-methacrylic acid gelatin hydrogel for wound healing and vascular regenerationJingrong Yu, Zhengkun Gao, Qingyue Han, et al.
Pageof 4